Amicogen (KRX: 092040)

Amicogen is a corporation based in Seoul, South Korea. Established in 2000, the company is a leader in global Industrial Biotechnology. It creates sustainability in the health industry and can reduce the consumption of energy, natural resources, and emissions of CO₂ and wastes by applying their specialty enzymes and microbes. The assets of the company are managed by the executive management team.